Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triazinones for treating irritable bowel syndrome

Triazinones for treating irritable bowel syndrome

US Patent 4562188 · Granted Dec 31, 1985

Estimated economic value: $3,459,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthesis of substituted N-heteroaromatic compounds and methods of use thereof1999
Pharmaceutically useful dibenzofurancarboxamides of specific stereo-configuratio1993
Pharmaceutically useful dibenzofurancarboxamides of specific stereo-configuratio1993
Prefabricated load bearing panel1993
Stereoselective reduction of 3-hydroxyket-1-ones to 1,3-syn-dihydroxylated compo1993
Quinoline derivatives as antagonists of leukotriene D41992
Process for the preparation of optically pure amides1992
Quinolinyl-benzopyran derivatives as antagonists of leukotriene D41992
Substituted saturated and unsaturated indole quinoline and benzazepine carboxami1991
Quinoline derivatives and their use as antagonists of leukotriene D.sub.41991
Quinoline derivatives as antagonists of leukotriene D.sub.41991
Quinoline derivatives as antagonists of leukotriene D41991